{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T09:54:36Z","timestamp":1780480476401,"version":"3.54.1"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2012,4,27]],"date-time":"2012-04-27T00:00:00Z","timestamp":1335484800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Neurooncol"],"published-print":{"date-parts":[[2012,8]]},"DOI":"10.1007\/s11060-012-0880-x","type":"journal-article","created":{"date-parts":[[2012,4,26]],"date-time":"2012-04-26T16:21:01Z","timestamp":1335457261000},"page":"143-148","source":"Crossref","is-referenced-by-count":72,"title":["Neurotoxicity of intra-CSF liposomal cytarabine (DepoCyt) administered for the treatment of leptomeningeal metastases: a retrospective case series"],"prefix":"10.1007","volume":"109","author":[{"given":"Marc C.","family":"Chamberlain","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2012,4,27]]},"reference":[{"issue":"5","key":"880_CR1","doi-asserted-by":"crossref","first-page":"702","DOI":"10.2165\/00003495-199141050-00003","volume":"41","author":"SM Blaney","year":"1991","unstructured":"Blaney SM, Balis FM, Poplack DG (1991) Current pharmacological treatment approaches to central nervous system leukemia. Drugs 41(5):702\u2013716","journal-title":"Drugs"},{"issue":"11","key":"880_CR2","first-page":"3394","volume":"5","author":"MJ Glantz","year":"1999","unstructured":"Glantz MJ, Jaeckle KA, Chamberlain MC et al (1999) A randomized controlled trial comparing intrathecal sustained-release cytarabine (DepoCyt) to intrathecal methotrexate in patients with neoplastic meningitis from solid tumors. Clin Cancer Res 5(11):3394\u20133402","journal-title":"Clin Cancer Res"},{"key":"880_CR3","doi-asserted-by":"crossref","first-page":"3110","DOI":"10.1200\/JCO.1999.17.10.3110","volume":"17","author":"MJ Glantz","year":"1999","unstructured":"Glantz MJ, LaFollette S, Jaeckle KA et al (1999) Randomized trial of a slow release vs. a standard formulation of cytarabine for the intrathecal treatment of lymphomatous meningitis. J Clin Oncol 17:3110\u20133116","journal-title":"J Clin Oncol"},{"key":"880_CR4","doi-asserted-by":"crossref","unstructured":"Shapiro WR, Schmid M, Glantz M, Miller JJ (2006) A randomized phase III\/IV study to determine benefit and safety of cytarabine liposome injection for treatment of neoplastic meningitis. J Clin Oncol 24(6 Suppl):1528 (abstract)","DOI":"10.1200\/jco.2006.24.18_suppl.1528"},{"key":"880_CR5","doi-asserted-by":"crossref","first-page":"2726","DOI":"10.1016\/j.ejca.2004.08.012","volume":"40","author":"W Boogerd","year":"2004","unstructured":"Boogerd W, van den Bent MJ, Koehler PJ, Heimans JJ, Van der Sande JJ et al (2004) The relevance of intraventricular chemotherapy for leptomeningeal metastasis in breast cancer: a randomized study. Eur J Cancer 40:2726\u20132733","journal-title":"Eur J Cancer"},{"issue":"3","key":"880_CR6","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1007\/s00277-008-0645-y","volume":"88","author":"YL Kwong","year":"2009","unstructured":"Kwong YL, Yeung DY, Chan JC (2009) Intrathecal chemotherapy for hematologic malignancies: drugs and toxicities. Ann Hematol 88(3):193\u2013201","journal-title":"Ann Hematol"},{"issue":"1","key":"880_CR7","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2165\/00003088-200544010-00001","volume":"44","author":"G Fleischhack","year":"2005","unstructured":"Fleischhack G, Jaehde U, Bode U (2005) Pharmacokinetics following intraventricular administration of chemotherapy in patients with neoplastic meningitis. Clin Pharmacokinet 44(1):1\u201331","journal-title":"Clin Pharmacokinet"},{"key":"880_CR8","doi-asserted-by":"crossref","unstructured":"Goekbuget N, Hartog CM, Bassan R, Derigs HG, Dombret H, Greil R, Hernandez-Rivas JM, Huguet F, Intermesoli T, Jourdan E, Junghanss C, Leimer L, Moreno MJ, Reichle A, Ribera JM, Schmid M, Serve H, Stelljes M, Stuhlmann R, Hoelzer D (2010) Liposomal ara-C is effective and tolerable in the treatment of CNS relapse of acute lymphoblastic leukemia (ALL) and aggressive lymphoma. Haematologica [Epub Ahead of Print]","DOI":"10.3324\/haematol.2010.028092"},{"issue":"3","key":"880_CR9","first-page":"505","volume":"9","author":"MC Chamberlain","year":"1996","unstructured":"Chamberlain MC, Kormanik P (1996) Leptomeningeal metastases due to melanoma: combined modality therapy. Int J Oncol 9(3):505\u2013510","journal-title":"Int J Oncol"},{"key":"880_CR10","doi-asserted-by":"crossref","first-page":"694","DOI":"10.3171\/jns.1997.87.5.0694","volume":"87","author":"MC Chamberlain","year":"1997","unstructured":"Chamberlain MC, Kormanik PA, Barba D (1997) Complications associated with intraventricular chemotherapy in patients with leptomeningeal metastases. J Neurosurg 87:694\u2013699","journal-title":"J Neurosurg"},{"key":"880_CR11","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1001\/archneur.55.4.506","volume":"55","author":"MC Chamberlain","year":"1998","unstructured":"Chamberlain MC, Kormanik PA (1998) Carcinomatous meningitis secondary to non-small cell lung cancer: combined modality therapy. Arch Neurol 55:506\u2013512","journal-title":"Arch Neurol"},{"key":"880_CR12","doi-asserted-by":"crossref","first-page":"1728","DOI":"10.1212\/WNL.49.6.1728","volume":"49","author":"MC Chamberlain","year":"1997","unstructured":"Chamberlain MC, Kormanik PA (1997) Non-AIDS related lymphomatous meningitis: combined modality therapy. Neurology 49:1728\u20131731","journal-title":"Neurology"},{"key":"880_CR13","first-page":"521","volume":"5","author":"MC Chamberlain","year":"1998","unstructured":"Chamberlain MC, Kormanik P, Glantz M (1998) Recurrent primary central nervous system lymphoma complicated by lymphomatous meningitis. Oncol Rep 5:521\u2013523","journal-title":"Oncol Rep"},{"key":"880_CR14","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1227\/01.NEU.0000043929.31608.62","volume":"52","author":"MC Chamberlain","year":"2003","unstructured":"Chamberlain MC (2003) Combined modality treatment of leptomeningeal gliomatosis. Neurosurgery 52:324\u2013330","journal-title":"Neurosurgery"},{"key":"880_CR15","doi-asserted-by":"crossref","first-page":"1851","DOI":"10.1002\/cncr.22619","volume":"109","author":"MC Chamberlain","year":"2007","unstructured":"Chamberlain MC, Chalmers L (2007) Acute binocular blindness. Cancer 109:1851\u20131854","journal-title":"Cancer"},{"key":"880_CR16","doi-asserted-by":"crossref","first-page":"1562","DOI":"10.1002\/cncr.23330","volume":"112","author":"M Chamberlain","year":"2008","unstructured":"Chamberlain M, Glantz MJ (2008) Myelomatous meningitis: multimodal therapy. Cancer 112:1562\u20131567","journal-title":"Cancer"},{"issue":"3","key":"880_CR17","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1007\/s11060-008-9707-1","volume":"91","author":"MC Chamberlain","year":"2009","unstructured":"Chamberlain MC, Johnston S, Van Horn A, Glantz MJ (2009) Recurrent lymphomatous meningitis treated with intra-CSF rituximab and liposomal ara-C. J Neurooncol 91(3):271\u2013277","journal-title":"J Neurooncol"},{"key":"880_CR18","doi-asserted-by":"crossref","unstructured":"Jabbour E, O\u2019Brien S, Kantarjian H, Garcia-Manero G, Ferrajoli A, Ravandi F, Cabanillas M, Thomas DA (2007) Neurological complications associated with intrathecal liposomal cytarabine given prophylactically in combination with high dose methotrexate and cytarabine to patients with acute lymphocytic leukemia. Blood [Epub Ahead of Print]","DOI":"10.1182\/blood-2006-08-043646"},{"issue":"12","key":"880_CR19","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1007\/s00277-008-0546-0","volume":"87","author":"I Hilgendorf","year":"2008","unstructured":"Hilgendorf I, Wolff D, Junghanss C, Kahl C, Leithaeuser M, Steiner B, Casper J, Freund M (2008) Neurological complications after intrathecal liposomal cytarabine application in patients after allogenic hematopoietic stem cell transplantation. Ann Hematol 87(12):1009\u20131012","journal-title":"Ann Hematol"},{"key":"880_CR20","doi-asserted-by":"crossref","unstructured":"G\u00e1llego P\u00e9rez-Larraya J, Palma JA, Carmona-Iragui M, Fern\u00e1ndez-Torr\u00f3n R, Irimia P, Rodr\u00edguez-Otero P, Panizo C, Mart\u00ednez-Vila E (2010) Neurologic complications of intrathecal liposomal cytarabine administered prophylactic ally to patients with non-Hodgkin\u2019s lymphoma. J Neurooncol [Epub Ahead of Print]","DOI":"10.1007\/s11060-010-0428-x"},{"key":"880_CR21","doi-asserted-by":"crossref","unstructured":"Ostermann K, Pels H, Kowoll A, Kuhnhenn J, Schlegel U (2010) Neurological complications after intrathecal liposomal cytarabine in combination with systemic polychemotherapy in primary CNS lymphoma. J Neurooncol [Epub Ahead of Print]","DOI":"10.1007\/s11060-010-0435-y"},{"issue":"1","key":"880_CR22","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1007\/s11912-003-0085-8","volume":"5","author":"T Siegal","year":"2003","unstructured":"Siegal T (2003) Toxicity for treatment of neoplastic meningitis. Curr Oncol Rep 5(1):41\u201349","journal-title":"Curr Oncol Rep"},{"issue":"11","key":"880_CR23","doi-asserted-by":"crossref","first-page":"3034","DOI":"10.1002\/1097-0142(19941201)74:11<3034::AID-CNCR2820741122>3.0.CO;2-O","volume":"74","author":"J Watterson","year":"1994","unstructured":"Watterson J, Toogood I, Nieder M, Morse M, Frierdich S, Lee Y, Moertel CL, Priest JR (1994) Excessive spinal cord toxicity from intensive central nervous system-directed therapies. Cancer 74(11):3034\u20133041","journal-title":"Cancer"}],"container-title":["Journal of Neuro-Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11060-012-0880-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11060-012-0880-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11060-012-0880-x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,7,6]],"date-time":"2020-07-06T19:13:25Z","timestamp":1594062805000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11060-012-0880-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,4,27]]},"references-count":23,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2012,8]]}},"alternative-id":["880"],"URL":"https:\/\/doi.org\/10.1007\/s11060-012-0880-x","relation":{},"ISSN":["0167-594X","1573-7373"],"issn-type":[{"value":"0167-594X","type":"print"},{"value":"1573-7373","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,4,27]]}}}